Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer's disease: A focus on human studies

Pharmacological Research

Volumn 131, Issue , 2018, Pages 32-43

  Pistollato, Francesca ^a   Iglesias, Ruben Calderón ^a   Ruiz, Roberto ^a   Aparicio, Silvia ^a   Crespo, Jorge ^a   Lopez, Luis Dzul ^b   Manna, Piera Pia ^c   Giampieri, Francesca ^c   Battino, Maurizio ^c  

^a Universidad Europea del Atlántico   (Spain)

^b Area de Nutrición y Salud Universidad Internacional Iberoamericana UNINI   (Mexico)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Alzheimer's disease; Cognitive functions; DASH diet; Dementia; Mediterranean diet; MIND diet; Nutrient supplementations

Indexed keywords

ALPHA TOCOPHEROL; BIOCURCUMAX; CURCUMA LONGA EXTRACT; CURCUMIN; CYANOCOBALAMIN; DONEPEZIL; EXTRA VIRGIN OLIVE OIL; FOLIC ACID; GENISTEIN; HOMOCYSTEINE; MECOBALAMIN; NUTRACEUTICAL; OMEGA 3 FATTY ACID; PLACEBO; PROTEIN CONCENTRATE PLUS CARBOHYDRATES PLUS LIPIDS PLUS MINERALS PLUS VITAMINS; PYRIDOXINE; RESVERATROL; SULFORAPHANE; THIAMINE; VITAMIN D;

ALZHEIMER DISEASE; BRAIN SIZE; CALORIC RESTRICTION; COMORBIDITY; DAIRY PRODUCT; DASH DIET; DEMENTIA; DIET SUPPLEMENTATION; DIETARY COMPLIANCE; ENDOCRINE DISEASE; HEALTHY DIET; HUMAN; MEDI DIET; MEDITERRANEAN DIET; METABOLIC DISORDER; MILD COGNITIVE IMPAIRMENT; MIND DIET; NEUROPROTECTION; NONHUMAN; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SEA FOOD; VITAMIN SUPPLEMENTATION; ANALYSIS; DIET THERAPY; DIETARY SUPPLEMENT; HYPERTENSION; METABOLISM; PROCEDURES; RISK FACTOR;

ALZHEIMER DISEASE; DEMENTIA; DIET THERAPY; DIET, MEDITERRANEAN; DIETARY SUPPLEMENTS; HEALTHY DIET; HUMANS; HYPERTENSION; RISK FACTORS;

EID: 85044387544     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2018.03.012     Document Type: Review

References (230)

1. A.s.D, International Dementia Statistics. 2018 https://www.alz.co.uk/research/statisticsm (Accessed December 9, 2017).
2. Wimo, A., Jonsson, L., Bond, J., Prince, M., Winblad, B., I. Alzheimer disease, the worldwide economic impact ofdementia 2010. Alzheimer's Dement. 9 (2013), 1–11 (e13).
3. Cummings, J.L., Morstorf, T., Zhong, K., Alzheimer's disease drug-development pipeline: few candidates, frequent failures. Alzheimer's Res. Ther., 6, 2014, 37.
4. Pippin, J.J., Retiring the Amyloid Cascade Hypothesis as a Cause of Alzheimer's. 2017 http://www.pcrm.org/research/good-science/retiring-the-amyloid-cascade-hypothesis-as-a-cause-of-alzheimers.
5. Sperling, R.A., Aisen, P.S., Beckett, L.A., Bennett, D.A., Craft, S., Fagan, A.M., Iwatsubo, T., Jack, C.R. Jr., Kaye, J., Montine, T.J., Park, D.C., Reiman, E.M., Rowe, C.C., Siemers, E., Stern, Y., Yaffe, K., Carrillo, M.C., Thies, B., Morrison-Bogorad, M., Wagster, M.V., Phelps, C.H., Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dement. 7 (2011), 280–292.
6. Schelke, M.W., Hackett, K., Chen, J.L., Shih, C., Shum, J., Montgomery, M.E., Chiang, G.C., Berkowitz, C., Seifan, A., Krikorian, R., Isaacson, R.S., Nutritional interventions for Alzheimer's prevention: a clinical precision medicine approach. Ann. N. Y. Acad. Sci. 1367 (2016), 50–56.
7. Oboudiyat, C., Glazer, H., Seifan, A., Greer, C., Isaacson, R.S., Alzheimer's disease. Semin. Neurol. 33 (2013), 313–329.
8. Nicolia, V., Lucarelli, M., Fuso, A., Environment, epigenetics and neurodegeneration: focus on nutrition in Alzheimer's disease. Experimentalgerontology 68 (2014), 8–12.
9. Pistollato, F., Battino, M., Role of plant-based diets in the prevention and regression of metabolic syndrome and neurodegenerative diseases. Trends Food Sci. Technol. 40 (2014), 62–81.
10. Morris, M.C., Evans, D.A., Bienias, J.L., Tangney, C.C., Bennett, D.A., Aggarwal, N., Schneider, J., Wilson, R.S., Dietary fats and the risk of incident Alzheimer disease. Arch. Neurol. 60 (2003), 194–200.
11. Greenwood, C.E., Parrott, M.D., Nutrition as a component of dementia risk reduction strategies. Healthc. Manage. Forum 30 (2017), 40–45.
12. Virmani, A., Pinto, L., Binienda, Z., Ali, S., Food, nutrigenomics, and neurodegeneration–neuroprotection by what you eat!. Mol. Neurobiol. 48 (2013), 353–362.
13. Berti, V., Murray, J., Davies, M., Spector, N., Tsui, W.H., Li, Y., Williams, S., Pirraglia, E., Vallabhajosula, S., McHugh, P., Pupi, A., de Leon, M.J., Mosconi, L., Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals. J. Nutr. Health Aging 19 (2015), 413–423.
14. Mosconi, L., Murray, J., Davies, M., Williams, S., Pirraglia, E., Spector, N., Tsui, W.H., Li, Y., Butler, T., Osorio, R.S., Glodzik, L., Vallabhajosula, S., McHugh, P., Marmar, C.R., de Leon, M.J., Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study. BMJ Open, 4, 2014, e004850.
15. Feart, C., Samieri, C., Alles, B., Barberger-Gateau, P., Potential benefits of adherence to the Mediterranean diet on cognitive health. Proc. Nutr. Soc. 72 (2013), 140–152.
16. Anastasiou, C.A., Yannakoulia, M., Kosmidis, M.H., Dardiotis, E., Hadjigeorgiou, G.M., Sakka, P., Arampatzi, X., Bougea, A., Labropoulos, I., Scarmeas, N., Mediterranean diet and cognitive health: initial results from the Hellenic Longitudinal Investigation of Ageing and Diet. PLoS One, 12, 2017, e0182048.
17. Willette, A.A., Johnson, S.C., Birdsill, A.C., Sager, M.A., Christian, B., Baker, L.D., Craft, S., Oh, J., Statz, E., Hermann, B.P., Jonaitis, E.M., Koscik, R.L., La Rue, A., Asthana, S., Bendlin, B.B., Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Alzheimer's Dement. 11 (2014), 504–510.
18. Kenna, H., Hoeft, F., Kelley, R., Wroolie, T., DeMuth, B., Reiss, A., Rasgon, N., Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease. Neurobiol. Aging 34 (2013), 641–649.
19. Cherbuin, N., Sachdev, P., Anstey, K.J., Higher normal fasting plasma glucose is associated with hippocampal atrophy: the PATH Study. Neurology 79 (2012), 1019–1026.
20. Ferreira, S.T., Clarke, J.R., Bomfim, T.R., De Felice, F.G., Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease. Alzheimer's Dement. 10 (2014), S76–83.
21. Morris, J.K., Vidoni, E.D., Honea, R.A., Burns, J.M., I. Alzheimer's Disease Neuroimaging, Impaired glycemia increases disease progression in mild cognitive impairment. Neurobiol. Aging 35 (2014), 585–589.
22. Rosendorff, C., Beeri, M.S., Silverman, J.M., Cardiovascular risk factors for Alzheimer's disease. Am. J. Geriatr. Cardiol. 16 (2007), 143–149.
23. Blom, K., Emmelot-Vonk, M.H., Koek, H.L., The influence of vascular risk factors on cognitive decline in patients with dementia: a systematic review. Maturitas 76 (2013), 113–117.
24. Dai, Y., Kamal, M.A., Fighting Alzheimer's disease and type 2 diabetes: pathological links and treatment strategies. CNS Neurol. Disord. Drug Targets 13 (2014), 271–282.
25. de la Monte, S.M., Tong, M., Brain metabolic dysfunction at the core of Alzheimer's disease. Biochem. Pharmacol. 88 (2014), 548–559.
26. Hao, K., Di Narzo, A.F., Ho, L., Luo, W., Li, S., Chen, R., Li, T., Dubner, L., Pasinetti, G.M., Shared genetic etiology underlying alzheimer's Disease and type 2 Diabetes. Mol. Aspects Med. 43 (2015), 66–76.
27. Rodriguez-Casado, A., Toledano-Diaz, A., Toledano, A., Defective insulin signalling, mediated by inflammation, connects obesity to alzheimer disease; relevant pharmacological therapies and preventive dietary interventions. Curr. Alzheimer Res. 14 (2017), 894–911.
28. Milionis, H.J., Florentin, M., Giannopoulos, S., Metabolic syndrome and Alzheimer's disease: a link to a vascular hypothesis?. CNS Spectr. 13 (2008), 606–613.
29. Willette, A.A., Johnson, S.C., Birdsill, A.C., Sager, M.A., Christian, B., Baker, L.D., Craft, S., Oh, J., Statz, E., Hermann, B.P., Jonaitis, E.M., Koscik, R.L., La Rue, A., Asthana, S., Bendlin, B.B., Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Alzheimer's Dement. 11 (2015), 504–510 (e501).
30. Pistollato, F., Sumalla Cano, S., Elio, I., Masias Vergara, M., Giampieri, F., Battino, M., The use of neuroimaging to assess associations among diet, nutrients, metabolic syndrome, and Alzheimer's disease. J. Alzheimers Dis. 48 (2015), 303–331.
31. Baloyannis, S.J., Mitochondrial alterations in Alzheimer's disease. J. Alzheimers Dis. 9 (2006), 119–126.
32. Picone, P., Nuzzo, D., Caruana, L., Scafidi, V., Di Carlo, M., Mitochondrial dysfunction: different routes to Alzheimer's disease therapy. Oxid. Med. Cell Longev., 2014, 2014, 780179.
33. Devi, L., Prabhu, B.M., Galati, D.F., Avadhani, N.G., Anandatheerthavarada, H.K., Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J. Neurosci. 26 (2006), 9057–9068.
34. Du, H., Guo, L., Yan, S., Sosunov, A.A., McKhann, G.M., Yan, S.S., Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 18670–18675.
35. Dominguez, L.J., Barbagallo, M., Dietary approaches and supplements in the prevention of cognitive decline and Alzheimer's disease. Curr. Pharm. Des. 22 (2016), 688–700.
36. Rosenberg, A., Ngandu, T., Rusanen, M., Antikainen, R., Backman, L., Havulinna, S., Hanninen, T., Laatikainen, T., Lehtisalo, J., Levalahti, E., Lindstrom, J., Paajanen, T., Peltonen, M., Soininen, H., Stigsdotter-Neely, A., Strandberg, T., Tuomilehto, J., Solomon, A., Kivipelto, M., Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: the FINGER trial. Alzheimer's Dement. 14 (2017), 263–270.
37. Shea, T.B., Remington, R., Nutritional supplementation for Alzheimer's disease?. Curr. Opin. Psychiatry 28 (2015), 141–147.
38. Rossor, M.N., Fox, N.C., Freeborough, P.A., Harvey, R.J., Clinical features of sporadic and familial Alzheimer's disease. Neurodegeneration 5 (1996), 393–397.
39. Chai, C.K., The genetics of Alzheimer's disease. Am. J. Alzheimer's Dis. Other Dement. 22 (2007), 37–41.
40. Gatz, M., Reynolds, C.A., Fratiglioni, L., Johansson, B., Mortimer, J.A., Berg, S., Fiske, A., Pedersen, N.L., Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry 63 (2006), 168–174.
41. Kang, S., Lee, Y.H., Lee, J.E., Metabolism-Centric overview of the pathogenesis of Alzheimer's disease. Yonsei Med. J. 58 (2017), 479–488.
42. Farina, N., Jerneren, F., Turner, C., Hart, K., Tabet, N., Homocysteine concentrations in the cognitive progression of Alzheimer's disease. Exp. Gerontol. 99 (2017), 146–150.
43. Pistollato, F., Sumalla Cano, S., Elio, I., Masias Vergara, M., Giampieri, F., Battino, M., Associations between sleep, cortisol regulation, and diet: possible implications for the risk of Alzheimer disease. Adv. Nutr. 7 (2016), 679–689.
44. Mattson, M.P., Will caloric restriction and folate protect against AD and PD?. Neurology 60 (2003), 690–695.
45. Rojas-Gutierrez, E., Munoz-Arenas, G., Trevino, S., Espinosa, B., Chavez, R., Rojas, K., Flores, G., Diaz, A., Guevara, J., Alzheimer's disease and metabolic syndrome: a link from oxidative stress and inflammation to neurodegeneration. Synapse, 2017.
46. Bloom, G.S., Lazo, J.S., Norambuena, A., Reduced brain insulin signaling: a seminal process in Alzheimer's disease pathogenesis. Neuropharmacology, 2017 pii: S0028-3908(17)30433-1.
47. Davies, J., Zachariades, E., Rogers-Broadway, K.R., Karteris, E., Elucidating the role of DEPTOR in Alzheimer's disease. Int. J. Mol. Med. 34 (2014), 1195–1200.
48. Duthie, A., Chew, D., Soiza, R.L., Non-psychiatric comorbidity associated with Alzheimer's disease. QJM: Monthly J. Assoc. Phys. 104 (2011), 913–920.
49. de la Torre, J.C., How do heart disease and stroke become risk factors for Alzheimer's disease?. Neurol. Res. 28 (2006), 637–644.
50. Lee, T.A., Wolozin, B., Weiss, K.B., Bednar, M.M., Assessment of the emergence of Alzheimer's disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty. J. Alzheimers Dis. 7 (2005), 319–332.
51. Lima, L.M., Carvalho, M., Ferreira, C.N., Fernandes, A.P., Neto, C.P., Garcia, J.C., Reis, H.J., Janka, Z., Palotas, A., Sousa, M., Atheromatosis extent in coronary artery disease is not correlated with apolipoprotein-E polymorphism and its plasma levels, but associated with cognitive decline. Curr. Alzheimer Res. 7 (2010), 556–563.
52. Koschack, J., Irle, E., Small hippocampal size in cognitively normal subjects with coronary artery disease. Neurobiol. Aging 26 (2005), 865–871.
53. Ikram, M.A., van Oijen, M., de Jong, F.J., Kors, J.A., Koudstaal, P.J., Hofman, A., Witteman, J.C., Breteler, M.M., Unrecognized myocardial infarction in relation to risk of dementia and cerebral small vessel disease. Stroke 39 (2008), 1421–1426.
54. Roberts, R.O., Knopman, D.S., Geda, Y.E., Cha, R.H., Roger, V.L., Petersen, R.C., Coronary heart disease is associated with non-amnestic mild cognitive impairment. Neurobiol. Aging 31 (2010), 1894–1902.
55. Zulli, R., Nicosia, F., Borroni, B., Agosti, C., Prometti, P., Donati, P., De Vecchi, M., Turini, D., Romanelli, G., Grassi, V., Padovani, A., Increased prevalence of silent myocardial ischaemia and severe ventricular arrhythmias in untreated patients with Alzheimer's disease and mild cognitive impairment without overt coronary artery disease. Clin. Neurol. Neurosurg. 110 (2008), 791–796.
56. Roman, G.C., Vascular dementia prevention: a risk factor analysis. Cerebrovasc. Dis. 20:Suppl. 2 (2005), 91–100.
57. Polidori, M.C., Mariani, E., Mecocci, P., Nelles, G., Congestive heart failure and Alzheimer's disease. Neurol. Res. 28 (2006), 588–594.
58. Muqtadar, H., Testai, F.D., Gorelick, P.B., The dementia of cardiac disease. Curr. Cardiol. Rep. 14 (2012), 732–740.
59. Reitz, C., Brickman, A.M., Luchsinger, J.A., Wu, W.E., Small, S.A., Tang, M.X., Frequency of subclinical heart disease in elderly persons with dementia. Am. J. Geriatr. Cardiol. 16 (2007), 183–188.
60. Daulatzai, M.A., Death by a thousand cuts in Alzheimer's disease: hypoxia–the prodrome. Neurotox. Res. 24 (2013), 216–243.
61. Bunch, T.J., Weiss, J.P., Crandall, B.G., May, H.T., Bair, T.L., Osborn, J.S., Anderson, J.L., Muhlestein, J.B., Horne, B.D., Lappe, D.L., Day, J.D., Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Heart Rhythm 7 (2010), 433–437.
62. Rusanen, M., Kivipelto, M., Levalahti, E., Laatikainen, T., Tuomilehto, J., Soininen, H., Ngandu, T., Heart diseases and long-term risk of dementia and Alzheimer's disease: a population-based CAIDE study. J. Alzheimers Dis. 42 (2014), 183–191.
63. Grammas, P., Sanchez, A., Tripathy, D., Luo, E., Martinez, J., Vascular signaling abnormalities in Alzheimer disease. Cleve. Clin. J. Med. 78:Suppl. 1 (2011), S50–53.
64. Grammas, P., Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J. Neuroinflammation, 8, 2011, 26.
65. Marchesi, V.T., Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. FASEB J. 25 (2011), 5–13.
66. Roher, A.E., Esh, C., Rahman, A., Kokjohn, T.A., Beach, T.G., Atherosclerosis of cerebral arteries in Alzheimer disease. Stroke 35 (2004), 2623–2627.
67. Roher, A.E., Tyas, S.L., Maarouf, C.L., Daugs, I.D., Kokjohn, T.A., Emmerling, M.R., Garami, Z., Belohlavek, M., Sabbagh, M.N., Sue, L.I., Beach, T.G., Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia. Alzheimer's Dement. 7 (2011), 436–444.
68. Beach, T.G., Wilson, J.R., Sue, L.I., Newell, A., Poston, M., Cisneros, R., Pandya, Y., Esh, C., Connor, D.J., Sabbagh, M., Walker, D.G., Roher, A.E., Circle of Willis atherosclerosis: association with Alzheimer's disease: neuritic plaques and neurofibrillary tangles. Acta Neuropathol. (Berl.) 113 (2007), 13–21.
69. Kalback, W., Esh, C., Castano, E.M., Rahman, A., Kokjohn, T., Luehrs, D.C., Sue, L., Cisneros, R., Gerber, F., Richardson, C., Bohrmann, B., Walker, D.G., Beach, T.G., Roher, A.E., Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease. Neurol. Res. 26 (2004), 525–539.
70. Guo, X., Pantoni, L., Simoni, M., Bengtsson, C., Bjorkelund, C., Lissner, L., Gustafson, D., Skoog, I., Blood pressure components and changes in relation to white matter lesions: a 32-year prospective population study. Hypertension 54 (2009), 57–62.
71. Skoog, I., Gustafson, D., Update on hypertension and Alzheimer's disease. Neurol. Res. 28 (2006), 605–611.
72. Qiu, C., Winblad, B., Fratiglioni, L., The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 4 (2005), 487–499.
73. O'Caoimh, R., Kehoe, P.G., Molloy, D.W., Renin Angiotensin aldosterone system inhibition in controlling dementia-related cognitive decline. J. Alzheimers Dis. 42:Suppl. 4 (2014), S575–586.
74. Hasnain, M., Vieweg, W.V., Possible role of vascular risk factors in Alzheimer's disease and vascular dementia. Curr. Pharm. Des. 20 (2014), 6007–6013.
75. Zhou, J., Yu, J.T., Wang, H.F., Meng, X.F., Tan, C.C., Wang, J., Wang, C., Tan, L., Association between stroke and Alzheimer's disease: systematic review and meta-analysis. J. Alzheimers Dis. 43 (2015), 479–489.
76. Csernansky, J.G., Dong, H., Fagan, A.M., Wang, L., Xiong, C., Holtzman, D.M., Morris, J.C., Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. Am. J. Psychiatry 163 (2006), 2164–2169.
77. Shumaker, S.A., Legault, C., Rapp, S.R., Thal, L., Wallace, R.B., Ockene, J.K., Hendrix, S.L., Jones, B.N. 3rd, Assaf, A.R., Jackson, R.D., Kotchen, J.M., Wassertheil-Smoller, S., Wactawski-Wende, J., Investigators, W., Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (2003), 2651–2662.
78. Suravarapu, S., Bergstralh, E.J., Farmer, S.A., Knopman, D.S., Jacobsen, S.J., Roberts, R.O., Dementia and low testosterone and bioavailable testosterone levels in men: possible increased risk. Alzheimer Dis. Assoc. Disord. 20 (2006), 138–140.
79. Hu, Y., Wang, Z.C., Guo, Q.H., Cheng, W., Chen, Y.W., Is thyroid status associated with cognitive impairment in elderly patients in China?. BMC Endocr. Disord., 16(11), 2016.
80. Samuels, M.H., Cognitive function in untreated hypothyroidism and hyperthyroidism. Curr. Opin. Endocrinol. Diabetes Obes. 15 (2008), 429–433.
81. Ceresini, G., Lauretani, F., Maggio, M., Ceda, G.P., Morganti, S., Usberti, E., Chezzi, C., Valcavi, R., Bandinelli, S., Guralnik, J.M., Cappola, A.R., Valenti, G., Ferrucci, L., Thyroid function abnormalities and cognitive impairment in elderly people: results of the Invecchiare in Chianti study. J. Am. Geriatr. Soc. 57 (2009), 89–93.
82. Correia, N., Mullally, S., Cooke, G., Tun, T.K., Phelan, N., Feeney, J., Fitzgibbon, M., Boran, G., O'Mara, S., Gibney, J., Evidence for a specific defect in hippocampal memory in overt and subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 94 (2009), 3789–3797.
83. Hogervorst, E., Huppert, F., Matthews, F.E., Brayne, C., Thyroid function and cognitive decline in the MRC Cognitive Function and Ageing Study. Psychoneuroendocrinology 33 (2008), 1013–1022.
84. Yong-Hong, L., Xiao-Dong, P., Chang-Quan, H., Bo, Y., Qing-Xiu, L., Hypothalamic-pituitary-thyroid axis in patients with Alzheimer disease (AD). J. Invest. Med. 61 (2013), 578–581.
85. van Boxtel, M.P., Menheere, P.P., Bekers, O., Hogervorst, E., Jolles, J., Thyroid function, depressed mood, and cognitive performance in older individuals: the Maastricht Aging Study. Psychoneuroendocrinology 29 (2004), 891–898.
86. Wahlin, A., Bunce, D., Wahlin, T.B., Longitudinal evidence of the impact of normal thyroid stimulating hormone variations on cognitive functioning in very old age. Psychoneuroendocrinology 30 (2005), 625–637.
87. Tan, Z.S., Beiser, A., Vasan, R.S., Au, R., Auerbach, S., Kiel, D.P., Wolf, P.A., Seshadri, S., Thyroid function and the risk of Alzheimer disease: the Framingham Study. Arch. Intern. Med. 168 (2008), 1514–1520.
88. Johansson, P., Almqvist, E.G., Johansson, J.O., Mattsson, N., Hansson, O., Wallin, A., Blennow, K., Zetterberg, H., Svensson, J., Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease. Psychoneuroendocrinology 38 (2013), 1058–1066.
89. Daghighi, M.H., Poureisa, M., Ahmadi, P., Reshadatjoo, M., Golestani, S., Naghavi-Behzad, M., Karkon-Shayan, F., Serum thyroid-stimulating hormone level and relation with size of hippocampus in patients with mild cognitive disorders. Nigerian Med. J. 57 (2016), 353–356.
90. Knopman, D.S., DeKosky, S.T., Cummings, J.L., Chui, H., Corey-Bloom, J., Relkin, N., Small, G.W., Miller, B., Stevens, J.C., Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56 (2001), 1143–1153.
91. Kim, M.S., Hwang, S.S., Park, E.J., Bae, J.W., Strict vegetarian diet improves the risk factors associated with metabolic diseases by modulating gut microbiota and reducing intestinal inflammation. Environ. Microbiol. Rep. 5 (2013), 765–775.
92. Pistollato, F., Sumalla Cano, S., Elio, I., Masias Vergara, M., Giampieri, F., Battino, M., Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. Nutr. Rev. 74 (2016), 624–634.
93. Hu, X., Wang, T., Jin, F., Alzheimer's disease and gut microbiota. Sci. China Life Sci. 59 (2016), 1006–1023.
94. Masoro, E.J., Overview of caloric restriction and ageing. Mech. Ageing Dev. 126 (2005), 913–922.
95. Ingram, D.K., Anson, R.M., de Cabo, R., Mamczarz, J., Zhu, M., Mattison, J., Lane, M.A., Roth, G.S., Development of calorie restriction mimetics as a prolongevity strategy. Ann. N. Y. Acad. Sci. 41:1019 (2004), 2–423.
96. Joseph, J., Cole, G., Head, E., Ingram, D., Nutrition, brain aging, and neurodegeneration. J. Neurosci. 29 (2009), 12795–12801.
97. Liu, M., Wilk, S.A., Wang, A., Zhou, L., Wang, R.H., Ogawa, W., Deng, C., Dong, L.Q., Liu, F., Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR. J. Biol. Chem. 285 (2010), 36387–36394.
98. Pani, G., Neuroprotective effects of dietary restriction: evidence and mechanisms. Semin. Cell Dev. Biol. 40 (2015), 106–114.
99. Calder, P.C., n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 83 (2006), 1505S–1519S.
100. Calder, P.C., Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol. Nutr. Food Res. 52 (2008), 885–897.
101. Connor, W.E., Connor, S.L., The importance of fish and docosahexaenoic acid in Alzheimer disease. Am. J. Clin. Nutr. 85 (2007), 929–930.
102. Lorente-Cebrian, S., Costa, A.G., Navas-Carretero, S., Zabala, M., Laiglesia, L.M., Martinez, J.A., Moreno-Aliaga, M.J., An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases. J. Physiol. Biochem. 71 (2015), 341–349.
103. Crichton, G.E., Elias, M.F., Torres, R.V., Sugar-sweetened soft drinks are associated with poorer cognitive function in individuals with type 2 diabetes: the Maine-Syracuse Longitudinal Study. Br. J. Nutr. 115 (2016), 1397–1405.
104. Pase, M.P., Himali, J.J., Beiser, A.S., Aparicio, H.J., Satizabal, C.L., Vasan, R.S., Seshadri, S., Jacques, P.F., Sugar- and artificially sweetened beverages and the risks of incident stroke and dementia: a prospective cohort study. Stroke 48 (2017), 1139–1146.
105. Brewer, G.J., Copper-2 ingestion, plus increased meat eating leading to increased copper absorption, are major factors behind the current epidemic of Alzheimer's disease. Nutrients 7 (2015), 10053–10064.
106. Granic, A., Davies, K., Adamson, A., Kirkwood, T., Hill, T.R., Siervo, M., Mathers, J.C., Jagger, C., Dietary patterns high in red meat, potato, gravy, and butter are associated with poor cognitive functioning but not with rate of cognitive decline in very old adults. J. Nutr. 146 (2016), 265–274.
107. Aune, D., Norat, T., Romundstad, P., Vatten, L.J., Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am. J. Clin. Nutr. 98 (2013), 1066–1083.
108. Diaz-Lopez, A., Bullo, M., Martinez-Gonzalez, M.A., Corella, D., Estruch, R., Fito, M., Gomez-Gracia, E., Fiol, M., Garcia de la Corte, F.J., Ros, E., Babio, N., Serra-Majem, L., Pinto, X., Munoz, M.A., Frances, F., Buil-Cosiales, P., Salas-Salvado, J., Dairy product consumption and risk of type 2 diabetes in an elderly Spanish Mediterranean population at high cardiovascular risk. Eur. J. Nutr. 55 (2016), 349–360.
109. Drouin-Chartier, J.P., Brassard, D., Tessier-Grenier, M., Cote, J.A., Labonte, M.E., Desroches, S., Couture, P., Lamarche, B., Systematic review of the association between dairy product consumption and risk of cardiovascular-related clinical outcomes. Adv. Nutr. 7 (2016), 1026–1040.
110. Gijsbers, L., Ding, E.L., Malik, V.S., de Goede, J., Geleijnse, J.M., Soedamah-Muthu, S.S., Consumption of dairy foods and diabetes incidence: a dose-response meta-analysis of observational studies. Am. J. Clin. Nutr. 103 (2016), 1111–1124.
111. Lovegrove, J.A., Givens, D.I., Dairy food products: good or bad for cardiometabolic disease?. Nutr. Res. Rev. 29 (2016), 249–267.
112. Wu, L., Sun, D., Meta-Analysis of milk consumption and the risk of cognitive disorders. Nutrients, 8, 2016.
113. Petruski-Ivleva, N., Kucharska-Newton, A., Palta, P., Couper, D., Meyer, K., Graff, M., Haring, B., Sharrett, R., Heiss, G., Milk intake at midlife and cognitive decline over 20 years. the atherosclerosis risk in communities (ARIC) study. Nutrients, 9, 2017.
114. van de Rest, O., Wang, Y., Barnes, L.L., Tangney, C., Bennett, D.A., Morris, M.C., APOE epsilon4 and the associations of seafood and long-chain omega-3 fatty acids with cognitive decline. Neurology 86 (2016), 2063–2070.
115. Zhang, Y., Chen, J., Qiu, J., Li, Y., Wang, J., Jiao, J., Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies. Am. J. Clin. Nutr. 103 (2016), 330–340.
116. Kroger, E., Fish, R., Consumption LaforceJr. brain mercury: and neuropathology in patients with Alzheimer disease and dementia. JAMA 315 (2016), 465–466.
117. Morris, M.C., Brockman, J., Schneider, J.A., Wang, Y., Bennett, D.A., Tangney, C.C., van de Rest, O., Association of seafood consumption, brain mercury level, and APOE epsilon4 status with brain neuropathology in older adults. JAMA 315 (2016), 489–497.
118. de Wilde, M.C., Vellas, B., Girault, E., Yavuz, A.C., Sijben, J.W., Lower brain and blood nutrient status in Alzheimer's disease: results from meta-analyses. Alzheimer's Dement. 3 (2017), 416–431.
119. Lopes da Silva, S., Vellas, B., Elemans, S., Luchsinger, J., Kamphuis, P., Yaffe, K., Sijben, J., Groenendijk, M., Stijnen, T., Plasma nutrient status of patients with Alzheimer's disease: systematic review and meta-analysis. Alzheimer's Dement. 10 (2014), 485–502.
120. van Wijk, N., Slot, R.E.R., Duits, F.H., Strik, M., Biesheuvel, E., Sijben, J.W.C., Blankenstein, M.A., Bierau, J., van der Flier, W.M., Scheltens, P., Teunissen, C.E., Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia. Alzheimers Dement. (Amst) 8 (2017), 139–146.
121. de van der Schueren, M.A., Lonterman-Monasch, S., van der Flier, W.M., Kramer, M.H., Maier, A.B., Muller, M., Malnutrition and risk of structural brain changes seen on magnetic resonance imaging in older adults. J. Am. Geriatr. Soc. 64 (2016), 2457–2463.
122. Etgen, T., Sander, D., Bickel, H., Sander, K., Forstl, H., Vitamin D deficiency, cognitive impairment and dementia: a systematic review and meta-analysis. Dement. Geriatr. Cogn. Disord. 33 (2012), 297–305.
123. Shen, L., Ji, H.F., Vitamin D deficiency is associated with increased risk of Alzheimer's disease and dementia: evidence from meta-analysis. Nutr. J., 14, 2015, 76.
124. Annweiler, C., Rolland, Y., Schott, A.M., Blain, H., Vellas, B., Herrmann, F.R., Beauchet, O., Higher vitamin D dietary intake is associated with lower risk of alzheimer's disease: a 7-year follow-up. J. Gerontol. A Biol. Sci. Med. Sci. 67 (2012), 1205–1211.
125. Gezen-Ak, D., Dursun, E., Bilgic, B., Hanagasi, H., Ertan, T., Gurvit, H., Emre, M., Eker, E., Ulutin, T., Uysal, O., Yilmazer, S., Vitamin D receptor gene haplotype is associated with late-onset Alzheimer's disease. Tohoku J. Exp. Med. 228 (2012), 189–196.
126. Kang, Y., Zhang, Y., Feng, Z., Liu, M., Li, Y., Yang, H., Wang, D., Zheng, L., Lou, D., Cheng, L., Chen, C., Zhou, W., Feng, Y., Li, X., Duan, J., Yu, M., Yang, S., Liu, Y., Wang, X., Deng, B., Liu, C., Yao, X., Zhu, C., Liang, C., Zeng, X., Ren, S., Li, Q., Zhong, Y., Zhang, Y., Kang, J., Yan, Y., Meng, H., Zhong, Z., Zhou, W., Wang, Y., Li, T., Song, W., Nutritional deficiency in early life facilitates aging-associated cognitive decline. Curr. Alzheimer Res. 14 (2017), 841–849.
127. Dauncey, M.J., Nutrition, the brain and cognitive decline: insights from epigenetics. Eur. J. Clin. Nutr. 68 (2014), 1179–1185.
128. Prado, E.L., Dewey, K.G., Nutrition and brain development in early life. Nutr. Rev. 72 (2014), 267–284.
129. Sun, J., Wen, S., Zhou, J., Ding, S., Association between malnutrition and hyperhomocysteine in Alzheimer's disease patients and diet intervention of betaine. J. Clin. Lab. Anal., 31, 2017.
130. Tombini, M., Sicari, M., Pellegrino, G., Ursini, F., Insarda, P., Di Lazzaro, V., Nutritional status of patients with alzheimer's disease and their caregivers. J. Alzheimers Dis. 54 (2016), 1619–1627.
131. Rullier, L., Lagarde, A., Bouisson, J., Bergua, V., Barberger-Gateau, P., Nutritional status of community-dwelling older people with dementia: associations with individual and family caregivers' characteristics. Int. J. Geriatr. Psychiatry 28 (2013), 580–588.
132. Roque, M., Salva, A., Vellas, B., Malnutrition in community-dwelling adults with dementia (NutriAlz Trial). J. Nutr. Health Aging 17 (2013), 295–299.
133. Bourre, J.M., Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J. Nutr. Health Aging 10 (2006), 377–385.
134. Nabavi, S.F., Sureda, A., Dehpour, A.R., Shirooie, S., Silva, A.S., Devi, K.P., Ahmed, T., Ishaq, N., Hashim, R., Sobarzo-Sanchez, E., Daglia, M., Braidy, N., Volpicella, M., Vacca, R.A., Nabavi, S.M., Regulation of autophagy by polyphenols: paving the road for treatment of neurodegeneration. Biotechnol. Adv., 2017.
135. Sawikr, Y., Yarla, N.S., Peluso, I., Kamal, M.A., Aliev, G., Bishayee, A., Neuroinflammation in Alzheimer's disease: the preventive and therapeutic potential of polyphenolic nutraceuticals. Adv. Protein Chem. Struct. Biol. 108 (2017), 33–57.
136. Sita, G., Hrelia, P., Tarozzi, A., Morroni, F., P-glycoprotein (ABCB1) and oxidative stress: focus on Alzheimer's disease. Oxid. Med. Cell Longev., 2017, 7905486 (2017).
137. Omar, S.H., Scott, C.J., Hamlin, A.S., Obied, H.K., The protective role of plant biophenols in mechanisms of Alzheimer's disease. J. Nutr. Biochem. 47 (2017), 1–2.
138. Zhang, R., Zhang, J., Fang, L., Li, X., Zhao, Y., Shi, W., An, L., Neuroprotective effects of sulforaphane on cholinergic neurons in mice with Alzheimer's disease-like lesions. Int. J. Mol. Sci. 15 (2014), 14396–14410.
139. Liu, Z.J., Li, Z.H., Liu, L., Tang, W.X., Wang, Y., Dong, M.R., Xiao, C., Curcumin attenuates beta-amyloid-induced neuroinflammation via activation of peroxisome proliferator-activated receptor-gamma function in a rat model of Alzheimer's disease. Front. Pharmacol., 7, 2016, 261.
140. Bonet-Costa, V., Herranz-Perez, V., Blanco-Gandia, M., Mas-Bargues, C., Ingles, M., Garcia-Tarraga, P., Rodriguez-Arias, M., Minarro, J., Borras, C., Garcia-Verdugo, J.M., Vina, J., Clearing amyloid-beta through PPARgamma/ApoE activation by genistein is a treatment of experimental Alzheimer's disease. J. Alzheimers Dis. 51 (2016), 701–771.
141. Engelborghs, S., Gilles, C., Ivanoiu, A., Vandewoude, M., Rationale and clinical data supporting nutritional intervention in Alzheimer's disease. Acta Clin. Belg. 69 (2014), 17–24.
142. Munoz Fernandez, S.S., Ivanauskas, T., Lima Ribeiro, S.M., Nutritional strategies in the management of Alzheimer disease: systematic review with network meta-analysis. J. Am. Med. Dir. Assoc. 18:897 (2017), e813–897 (e830).
143. Rijpma, A., Meulenbroek, O., Olde Rikkert, M.G., Cholinesterase inhibitors and add-on nutritional supplements in Alzheimer's disease: a systematic review of randomized controlled trials. Ageing Res. Rev. 16 (2014), 105–112.
144. Smith, A.D., Refsum, H., Homocysteine B vitamins: and cognitive impairment. Annu. Rev. Nutr. 36 (2016), 211–239.
145. van der Zwaluw, N.L., Brouwer-Brolsma, E.M., van de Rest, O., van Wijngaarden, J.P., In ‘t Veld, P.H., Kourie, D.I., Swart, K.M., Enneman, A.W., van Dijk, S.C., van der Velde, N., Kessels, R.P., Smeets, P.A., Kok, F.J., Dhonukshe-Rutten, R.A., de Groot, L.C., Folate and vitamin -related biomarkers in relation to brain volumes. Nutrients, 9, 2016, B12.
146. Chen, H., Liu, S., Ji, L., Wu, T., Ji, Y., Zhou, Y., Zheng, M., Zhang, M., Xu, W., Huang, G., Folic acid supplementation mitigates alzheimer's disease by reducing inflammation: a randomized controlled trial. Mediators Inflamm., 2016, 5912146 (2016).
147. Kwok, T., Lee, J., Ma, R.C., Wong, S.Y., Kung, K., Lam, A., Ho, C.S., Lee, V., Harrison, J., Lam, L., A randomized placebo controlled trial of vitamin B12 supplementation to prevent cognitive decline in older diabetic people with borderline low serum vitamin B12. Clin. Nutr. 36 (2017), 1509–1515.
148. Rommer, P.S., Fuchs, D., Leblhuber, F., Schroth, R., Greilberger, M., Tafeit, E., Greilberger, J., Lowered levels of carbonyl proteins after vitamin B supplementation in patients with mild cognitive impairment and Alzheimer's disease. Neuro-Degener. Dis. 16 (2016), 284–289.
149. Burckhardt, M., Herke, M., Wustmann, T., Watzke, S., Langer, G., Fink, A., Omega-3 fatty acids for the treatment of dementia. Cochrane Database Syst. Rev., 4, 2016, CD009002.
150. Canhada, S., Castro, K., Perry, I.S., Luft, V.C., Omega −3 fatty acids' supplementation in Alzheimer's disease: a systematic review. Nutr. Neurosci., 2017, 1–10.
151. Eriksdotter, M., Vedin, I., Falahati, F., Freund-Levi, Y., Hjorth, E., Faxen-Irving, G., Wahlund, L.O., Schultzberg, M., Basun, H., Cederholm, T., Palmblad, J., Plasma fatty acid profiles in relation to cognition and gender in alzheimer's disease patients during oral omega-3 fatty acid supplementation: the OmegAD study. J. Alzheimers Dis. 48 (2015), 805–881.
152. Farina, N., Llewellyn, D., Isaac, M., Tabet, N., Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database Syst. Rev., 4, 2017, CD002854.
153. Latimer, C.S., Brewer, L.D., Searcy, J.L., Chen, K.C., Popovic, J., Kraner, S.D., Thibault, O., Blalock, E.M., Landfield, P.W., Porter, N.M., Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rats. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), E4359–4366.
154. Yu, J., Gattoni-Celli, M., Zhu, H., Bhat, N.R., Sambamurti, K., Gattoni-Celli, S., Kindy, M.S., Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AbetaPP transgenic mice. J. Alzheimers Dis. 25 (2011), 295–307.
155. Landel, V., Annweiler, C., Millet, P., Morello, M., Feron, F., Vitamin D, cognition and Alzheimer's disease the therapeutic benefit is in the D-Tails. J. Alzheimers Dis. 53 (2016), 419–444.
156. Gupta, S.C., Sung, B., Kim, J.H., Prasad, S., Li, S., Aggarwal, B.B., Multitargeting by turmeric, the golden spice: from kitchen to clinic. Mol. Nutr. Food Res. 57 (2013), 1510–1528.
157. Shytle, R.D., Tan, J., Bickford, P.C., Rezai-Zadeh, K., Hou, L., Zeng, J., Sanberg, P.R., Sanberg, C.D., Alberte, R.S., Fink, R.C., Roschek, B. Jr., Optimized turmeric extract reduces beta-Amyloid and phosphorylated Tau protein burden in Alzheimer's transgenic mice. Curr. Alzheimer Res. 9 (2012), 500–506.
158. Smoliga, J.M., Baur, J.A., Hausenblas, H.A., Resveratrol and health–a comprehensive review of human clinical trials. Mol. Nutr. Food Res. 55 (2011), 1129–1141.
159. Bastianetto, S., Menard, C., Quirion, R., Neuroprotective action of resveratrol. Biochim. Biophys. Acta 119:1852 (2015), 5–1201.
160. Cox, K.H., Pipingas, A., Scholey, A.B., Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J. Psychopharmacol. 29 (2015), 642–665.
161. Rainey-Smith, S.R., Brown, B.M., Sohrabi, H.R., Shah, T., Goozee, K.G., Gupta, V.B., Martins, R.N., Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults. Br. J. Nutr. 115 (2016), 2106–2113.
162. Evans, H.M., Howe, P.R., Wong, R.H., Effects of resveratrol on cognitive performance, mood and cerebrovascular function in post-Menopausal women; a 14-Week randomised placebo-Controlled intervention trial. Nutrients, 9, 2017.
163. Genazzani, A.R., Bernardi, F., Pluchino, N., Begliuomini, S., Lenzi, E., Casarosa, E., Luisi, M., Endocrinology of menopausal transition and its brain implications. CNS Spectr. 10 (2005), 449–457.
164. Wong, R.H., Raederstorff, D., Howe, P.R., Acute Resveratrol Consumption Improves Neurovascular Coupling Capacity in Adults with Type 2 Diabetes Mellitus. Nutrients, 8, 2016.
165. Turner, R.S., Thomas, R.G., Craft, S., van Dyck, C.H., Mintzer, J., Reynolds, B.A., Brewer, J.B., Rissman, R.A., Raman, R., Aisen, S., A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology 85 (2015), 1383–1391.
166. Mazzanti, G., Di Giacomo, S., Curcumin and Resveratrol in the Management of Cognitive Disorders: what is the Clinical Evidence?. Molecules, 21, 2016.
167. de Waal, H., Stam, C.J., Lansbergen, M.M., Wieggers, R.L., Kamphuis, P.J., Scheltens, P., Maestu, F., van Straaten, E.C., The effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled study. PLoS One, 9, 2014, e86558.
168. Scheltens, P., Kamphuis, P.J., Verhey, F.R., Olde Rikkert, M.G., Wurtman, R.J., Wilkinson, D., Twisk, J.W., Kur, A., Efficacy of a medical food in mild Alzheimer's disease: a randomized, controlled trial. Alzheimer's Dement. 6 (2010), 1–10 (e11).
169. Scheltens, P., Twisk, J.W., Blesa, R., Scarpini, E., von Arnim, C.A., Bongers, A., Harrison, J., Swinkels, S.H., Stam, C.J., de Waal, H., Wurtman, R.J., Wieggers, R.L., Vellas, B., Kamphuis, P.J., Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J. Alzheimers Dis. 31 (2012), 225–236.
170. Soininen, H., Solomon, A., Visser, P.J., Hendrix, S.B., Blennow, K., Kivipelto, M., Hartmann, T., 24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial. Lancet Neurol. 16 (2017), 965–975.
171. Rijpma, A., Meulenbroek, O., van Hees, A.M., Sijben, J.W., Vellas, B., Shah, R.C., Bennett, D.A., Scheltens, P., Olde Rikkert, M.G., Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease. Alzheimer's Res. Ther., 7, 2015, 51.
172. Hartmann, T., van Wijk, N., Wurtman, R.J., Olde Rikkert, M.G., Sijben, J.W., Soininen, H., Vellas, B., Scheltens, P., A nutritional approach to ameliorate altered phospholipid metabolism in Alzheimer's disease. J. Alzheimers Dis. 41 (2014), 715–771.
173. Remington, R., Lortie, J.J., Hoffmann, H., Page, R., Morrell, C., Shea, T.B., A nutritional formulation for cognitive performance in mild cognitive impairment: a placebo-controlled trial with an open-label extension. J. Alzheimers Dis. 48 (2015), 591–595.
174. Remington, R., Bechtel, C., Larsen, D., Samar, A., Page, R., Morrell, C., Shea, T.B., Maintenance of cognitive performance and mood for individuals with Alzheimer's disease following consumption of a nutraceutical formulation: a one-Year, open-label study. J. Alzheimers Dis. 51 (2016), 991–999.
175. Solfrizzi, V., Custodero, C., Lozupone, M., Imbimbo, B.P., Valiani, V., Agosti, P., Schilardi, A., D'Introno, A., La Montagna, M., Calvani, M., Guerra, V., Sardone, R., Abbrescia, D.I., Bellomo, A., Greco, A., Daniele, A., Seripa, D., Logroscino, G., Sabba, C., Panza, F., Relationships of dietary patterns, foods, and micro- and macronutrients with alzheimer's disease and late-life cognitive disorders: a systematic review. J. Alzheimers Dis. 59 (2017), 815–884.
176. Mosconi, L., Murray, J., Tsui, W.H., Li, Y., Davies, M., Williams, S., Pirraglia, E., Spector, N., Osorio, R.S., Glodzik, L., McHugh, P., de Leon, M.J., Mediterranean diet and magnetic resonance imaging-assessed brain atrophy in cognitively normal individuals at risk for Alzheimer's disease. J. Preven. Alzheimer's Dis. 1 (2014), 23–32.
177. Scarmeas, N., Luchsinger, J.A., Stern, Y., Gu, Y., He, J., DeCarli, C., Brown, T., Brickman, A.M., Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease. Ann. Neurol. 69 (2011), 257–268.
178. Scarmeas, N., Stern, Y., Mayeux, R., Manly, J.J., Schupf, N., Luchsinger, J.A., Mediterranean diet and mild cognitive impairment. Arch. Neurol. 66 (2009), 216–225.
179. Titova, O.E., Ax, E., Brooks, S.J., Sjogren, P., Cederholm, T., Kilander, L., Kullberg, J., Larsson, E.M., Johansson, L., Ahlstrom, H., Lind, L., Schioth, H.B., Benedict, C., Mediterranean diet habits in older individuals: associations with cognitive functioning and brain volumes. Exp. Gerontol. 48 (2013), 1443–1448.
180. Scarmeas, N., Stern, Y., Mayeux, R., Luchsinger, J.A., Mediterranean diet, Alzheimer disease, and vascular mediation. Arch. Neurol. 63 (2006), 1709–1717.
181. Martinez-Lapiscina, E.H., Clavero, P., Toledo, E., Estruch, R., Salas-Salvado, J., San Julian, B., Sanchez-Tainta, A., Ros, E., Valls-Pedret, C., Martinez-Gonzalez, M.A., Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. J. Neurol. Neurosurg. Psychiatry 84 (2013), 1318–1325.
182. Valls-Pedret, C., Sala-Vila, A., Serra-Mir, M., Corella, D., de la Torre, R., Martinez-Gonzalez, M.A., Martinez-Lapiscina, E.H., Fito, M., Perez-Heras, A., Salas-Salvado, J., Estruch, R., Ros, E., Mediterranean diet and age-Related cognitive decline: a randomized clinical trial. JAMA Internalmed. 175 (2015), 1094–1103.
183. Petersson, S.D., Philippou, E., Mediterranean diet, cognitive function, and dementia: a systematic review of the evidence. Adv. Nutr. 7 (2016), 889–904.
184. Lourida, I., Soni, M., Thompson-Coon, J., Purandare, N., Lang, I.A., Ukoumunne, O.C., Llewellyn, D.J., Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology 24 (2013), 479–489.
185. Morris, M.C., Nutrition and risk of dementia: overview and methodological issues. Ann. N. Y. Acad. Sci. 1367 (2016), 31–37.
186. Appel, L.J., Moore, T.J., Obarzanek, E., Vollmer, W.M., Svetkey, L.P., Sacks, F.M., Bray, G.A., Vogt, T.M., Cutler, J.A., Windhauser, M.M., Lin, P.H., Karanja, N., A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N. Engl. J. Med. 336 (1997), 1117–1124.
187. Appel, L.J., Sacks, F.M., Carey, V.J., Obarzanek, E., Swain, J.F., Miller 3rd, E.R., Conlin, P.R., Erlinger, T.P., Rosner, B.A., Laranjo, N.M., Charleston, J., McCarron, P., Bishop, L.M., Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 294 (2005), 2455–2464.
188. Blumenthal, J.A., Babyak, M.A., Sherwood, A., Craighead, L., Lin, P.H., Johnson, J., Watkins, L.L., Wang, J.T., Kuhn, C., Feinglos, M., Hinderliter, A., Effects of the dietary approaches to stop hypertension diet alone and in combination with exercise and caloric restriction on insulin sensitivity and lipids. Hypertension 55 (2010), 1199–1205.
189. Asemi, Z., Tabassi, Z., Samimi, M., Fahiminejad, T., Esmaillzadeh, A., Favourable effects of the Dietary Approaches to Stop Hypertension diet on glucose tolerance and lipid profiles in gestational diabetes: a randomised clinical trial. Br. J. Nutr. 109 (2013), 2024–2030.
190. Erlinger, T.P., Miller, E.R. 3rd, Charleston, J., Appel, L.J., Inflammation modifies the effects of a reduced-fat low-cholesterol diet on lipids: results from the DASH-sodium trial. Circulation 108 (2003), 150–154.
191. Miller, E.R. 3rd, Erlinger, T.P., Sacks, F.M., Svetkey, L.P., Charleston, J., Lin, P.H., Appel, L.J., A dietary pattern that lowers oxidative stress increases antibodies to oxidized LDL: results from a randomized controlled feeding study. Atherosclerosis 183 (2005), 175–182.
192. Azadbakht, L., Surkan, P.J., Esmaillzadeh, A., Willett, W.C., The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients. J. Nutr. 141 (2011), 1083–1088.
193. Elmer, P.J., Obarzanek, E., Vollmer, W.M., Simons-Morton, D., Stevens, V.J., Young, D.R., Lin, P.H., Champagne, C., Harsha, D.W., Svetkey, L.P., Ard, J., Brantley, P.J., Proschan, M.A., Erlinger, T.P., Appel, L.J., Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann. Intern. Med. 144 (2006), 485–495.
194. Moore, T.J., Alsabeeh, N., Apovian, C.M., Murphy, M.C., Coffman, G.A., Cullum-Dugan, D., Jenkins, M., Cabral, H., Weight, blood pressure, and dietary benefits after 12 months of a Web-based Nutrition Education Program (DASH for health): longitudinal observational study. J. Med. Internet Res., 10, 2008, e52.
195. Gadgil, M.D., Appel, L.J., Yeung, E., Anderson, C.A., Sacks, F.M., Miller, E.R. 3rd, The effects of carbohydrate, unsaturated fat, and protein intake on measures of insulin sensitivity: results from the OmniHeart trial. Diabetes Care 36 (2013), 1132–1137.
196. Jannasch, F., Kroger, J., Schulze, M.B., Dietary patterns and type 2 diabetes: a systematic literature review and meta-analysis of prospective studies. J. Nutr. 147 (2017), 1174–1182.
197. Tangney, C.C., Li, H., Wang, Y., Barnes, L., Schneider, J.A., Bennett, D.A., Morris, M.C., Relation of DASH- and Mediterranean-like dietary patterns to cognitive decline in older persons. Neurology 83 (2014), 1410–1416.
198. Wengreen, H., Munger, R.G., Cutler, A., Quach, A., Bowles, A., Corcoran, C., Tschanz, J.T., Norton, M.C., Welsh-Bohmer, K.A., Prospective study of dietary approaches to stop hypertension- and mediterranean-style dietary patterns and age-related cognitive change: the cache county study on memory, health and aging. Am. J. Clin. Nutr. 98 (2013), 1263–1271.
199. Smith, P.J., Blumenthal, J.A., Babyak, M.A., Craighead, L., Welsh-Bohmer, K.A., Browndyke, J.N., Strauman, T.A., Sherwood, A., Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure. Hypertension 55 (2010), 1331–1338.
200. Blumenthal, J.A., Smith, P.J., Mabe, S., Hinderliter, A., Welsh-Bohmer, K., Browndyke, J.N., Lin, P.H., Kraus, W., Doraiswamy, P.M., Burke, J., Sherwood, A., Lifestyle and neurocognition in older adults with cardiovascular risk factors and cognitive impairment. Psychosom. Med. 79 (2017), 719–727.
201. Morris, M.C., Tangney, C.C., Wang, Y., Sacks, F.M., Bennett, D.A., Aggarwal, N.T., MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimer's Dement. 11 (2015), 1007–1014.
202. Devore, E.E., Kang, J.H., Breteler, M.M., Grodstein, F., Dietary intakes of berries and flavonoids in relation to cognitive decline. Ann. Neurol. 72 (2012), 135–143.
203. Willis, L.M., Shukitt-Hale, B., Joseph, J.A., Recent advances in berry supplementation and age-related cognitive decline. Curr. Opin. Clin. Nutr. Metab. Care 12 (2009), 91–94.
204. Jia, Y.P., Sun, L., Yu, H.S., Liang, L.P., Li, W., Ding, H., Song, X.B., Zhang, L.J., The pharmacological effects of lutein and zeaxanthin on visual disorders and cognition diseases. Molecules, 22, 2017.
205. Morris, M.C., Booth, S., Dawson-Hughes, B., Barnes, L., Bennett, D., Wang, Y., Relations to cognitive change with age of micronutrients found in green leafy vegetables. FASEB J., 29(260), 2015, 263.
206. Morris, M.C., Tangney, C.C., Wang, Y., Sacks, F.M., Barnes, L.L., Bennett, D.A., Aggarwal, N.T., Mediterranean-dietary approach to systolic hypertension diet intervention for neurodegenerative delay diet slows cognitive decline with aging. Alzheimer's Dement. 11 (2015), 1015–1022.
207. McEvoy, C.T., Guyer, H., Langa, K.M., Yaffe, K., Neuroprotective diets are associated with better cognitive function: the health and retirement study. J. Am. Geriatr. Soc. 65 (2017), 1857–1862.
208. Galvin, J.E., Prevention of alzheimer's disease: lessons learned and applied. J. Am. Geriatr. Soc. 65 (2017), 2128–2133.
209. Pistollato, F., Ohayon, E.L., Lam, A., Langley, G.R., Novak, T.J., Pamies, D., Perry, G., Trushina, E., Williams, R.S., Roher, A.E., Hartung, T., Harnad, S., Barnard, N., Morris, M.C., Lai, M.C., Merkley, R., Chandrasekera, P.C., Alzheimer disease research in the 21 st century: past and current failures: new perspectives and funding priorities. Oncotarget 7 (2016), 38999–39016.
210. Zhang, Y.H., Wang, D.W., Xu, S.F., Zhang, S., Fan, Y.G., Yang, Y.Y., Guo, S.Q., Wang, S., Guo, T., Wang, Z.Y., Guo, C., alpha-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice. Redox. Biol. 14 (2018), 535–548.
211. Jang, H., Lee, S., Choi, S.L., Kim, H.Y., Baek, S., Kim, Y., Taurine directly binds to oligomeric amyloid-beta and recovers cognitive deficits in alzheimer model mice. Adv. Exp. Med. Biol. 975 (2017), 233–241.
212. Zhang, Z.H., Wen, L., Wu, Q.Y., Chen, C., Zheng, R., Liu, Q., Ni, J.Z., Song, G.L., Long-term dietary supplementation with selenium-enriched yeast improves cognitive impairment, reverses synaptic deficits, and mitigates tau pathology in a triple transgenic mouse model of alzheimer's disease. J. Agric. Food Chem. 65 (2017), 4970–4979.
213. Zhang, Z.H., Wu, Q.Y., Zheng, R., Chen, C., Chen, Y., Liu, Q., Hoffmann, P.R., Ni, J.Z., Song, G.L., Selenomethionine mitigates cognitive decline by targeting both tau hyperphosphorylation and autophagic clearance in an Alzheimer's disease mouse model. J. Neurosci. 37 (2017), 2449–2462.
214. Peng, Y., Hou, C., Yang, Z., Li, C., Jia, L., Liu, J., Tang, Y., Shi, L., Li, Y., Long, J., Hydroxytyrosol mildly improve cognitive function independent of APP processing in APP/PS1 mice. Mol. Nutr. Food Res. 60 (2016), 2331–2342.
215. Grossi, C., Dami, T., Rigacci, S., Stefani, M., Luccarini, I., Casament, F., Employing Alzheimer disease animal models for translational research: focus on dietary components. Neuro-Degener. Dis. 13 (2014), 131–134.
216. Franco, R., Cedazo-Minguez, A., Successful therapies for Alzheimer's disease: why so many in animal models and none in humans?. Front. Pharmacol., 5, 2014, 146.
217. Cavanaugh, S.E., Pippin, J.J., Barnard, N.D., Animal models of Alzheimer disease: historical pitfalls and a path forward. ALTEX 31 (2014), 279–302.
218. Langley, G.R., Considering a new paradigm for Alzheimer's disease research. Drug Discovery Today 19 (2014), 1114–1124.
219. Windisch, M., We can treat Alzheimer's disease successfully in mice but not in men: failure in translation? A perspective. Neuro-degener. Dis. 13 (2014), 147–150.
220. Sabbagh, J.J., Kinney, J.W., Cummings, J.L., Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications. Neurobiol. Aging 34 (2013), 169–183.
221. Dodart, J.C., Mathis, C., Bales, K.R., Paul, S.M., Does my mouse have Alzheimer's disease?. Genes Brain Behav. 1 (2002), 142–155.
222. Duyckaerts, C., Potier, M.C., Delatour, B., Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol. (Berl.) 115 (2008), 5–38.
223. Romano, L., De Santis, G.L., Gualtieri, P., Merra, G., Thyroid disorders and Mediterranean diet: which way to prevent metabolic complications. Eur. Rev. Med. Pharmacol. Sci. 21 (2017), 3531–3532.
224. Pistollato, F., Role of dietary patterns in the prevention and regression of insulin resistance-related cancers. Mediterranean J. Nutr. Metab. 8 (2015), 37–49.
225. Abate, G., Marziano, M., Rungratanawanich, W., Memo, M., Uberti, D., Nutrition and AGE-ing. focusing on alzheimer's disease. Oxid. Med.Cell Longev., 2017, 2017, 7039816.
226. Adams, K.M., Lindell, K.C., Kohlmeier, M., Zeisel, S.H., Status of nutrition education in medical schools. Am. J. Clin. Nutr. 83 (2006), 941S–944S.
227. Eisenberg, D.M., Burgess, J.D., Nutrition education in an era of global obesity and diabetes: thinking outside the box. Acad. Med. 90 (2015), 854–860.
228. Hargrove, E.J., Berryman, D.E., Yoder, J.M., Beverly, E.A., Assessment of nutrition knowledge and attitudes in preclinical osteopathic medical students. J. Am. Osteopath. Assoc. 117 (2017), 622–663.
229. Abbatecola, A.M., Russo, M., Barbieri, M., Dietary patterns and cognition in older persons. Curr. Opin. Clin. Nutr. Metab. Care. 21 (2018), 10–13.
230. Roskoski, R. Jr., Guidelines for preparing color figures for everyone including the colorblind. Pharmacol. Res. 119 (2017), 240–241.